PaperRegulation of insulin-like growth factor binding proteins in ovarian cancer cells by oestrogen
References (30)
- et al.
Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6)
Prog Growth Factor Res
(1991) - et al.
Growth hormone dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts
Biochem Biophys Res Commun
(1988) - et al.
Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction
Anal Biochem
(1987) - et al.
Identification of five different insulin-like factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human
J Biol Chem
(1991) - et al.
Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies
Anal Biochem
(1986) - et al.
Binding proteins for the insulin-like growth factor: structure, regulation, and function
Prog Growth Factor Res
(1989) - et al.
Human insulin-like growth factor binding protein-6 is O-glycosylated
Biochem Biophys Res Commun
(1992) - et al.
Potential relevance of insulin-like growth factor I to ovarian physiology: from basic science to clinical application
Sem Reprod Endocrinol
(1989) - et al.
Expression of insulin-like growth factor-I, its binding proteins, and its receptor in ovarian cancer
Cancer Res
(1991) - et al.
Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define hormonal specificity
EMBO J
(1986)
Insulin-like growth factor II receptor as a multifunctional binding protein
Nature
(1987)
Estrogen and antiestrogen effects on the growth of human epithelial ovarian cancer in vitro
Obstet Gynecol
(1989)
Identification of insulin-like growth factor binding proteins in breast cancer cells
Breast Cancer Res Treat
(1991)
Cloning, sequence analysis and expression of cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2)
EMBO J
(1989)
Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human
Mol Endocrinol
(1990)
Cited by (35)
Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer
2014, Journal of Steroid Biochemistry and Molecular BiologyCitation Excerpt :Furthermore, estradiol also increases the number of IGF-I receptors per cell by approximately 50% in cultures from HGSC mesenteric metastases [114]. A study that first reported IGFBP3 mRNA in human ovarian cancer samples shows that estradiol reduces levels of the IGF-I inhibitor, IGFBP3, in ERα-positive PEO4 cells [115]. In support of these studies, Walker et al. show that estradiol reduces IGFBP3 and IGFBP5 levels and increases IGFBP4 levels via ERα in PEO4 ovarian cancer cells, which is reversed by tamoxifen treatment.
Role of astroglia and insulin-like growth factor-I in gonadal hormone- dependent synaptic plasticity
1997, Brain Research BulletinDiagnostic accuracy of serum insulin-like growth factor-binding protein 2 for ovarian cancer
2020, International Journal of Gynecological CancerOvarian epithelial tumors and reproductive factors: A systematic review
2013, Archives of Gynecology and Obstetrics
Copyright © 1993 Published by Elsevier Ltd.